Quarterly Revenue Increases 15 Percent Year
over Year to Record $78.2 Million
Proto Labs, Inc. (NYSE:PRLB), a leading online and
technology-enabled, quick-turn, on-demand manufacturer, today
announced financial results for the third quarter ended September
30, 2016.
Third Quarter 2016 Highlights include:
- Revenue for the third quarter of 2016
was $78.2 million, 15 percent above revenue of $67.8 million in the
third quarter of 2015. Alphaform, the German company acquired in
the fourth quarter of 2015, represented $4.0 million in revenue in
the third quarter. Excluding this contribution, legacy revenue
totaled $74.2 million, an increase of nine percent compared with
the third quarter of 2015.
- Revenue from 3D printing was $9.9
million. Excluding Alphaform’s $2.0 million in 3D printing revenue,
legacy 3D printing revenue was $7.9 million, an increase of 30
percent from the third quarter of 2015.
- The number of unique product developers
and engineers served increased 14 percent to 14,271 from 12,541 in
the third quarter a year ago.
- Net income for the third quarter of
2016 was $12.0 million, or $0.45 per diluted share. Non-GAAP net
income, excluding the after-tax expense of stock compensation,
amortization of intangibles, charges related to the exit of
facilities and unrealized foreign currency gains, was $13.5
million, or $0.51 per diluted share. See “Non-GAAP Financial
Measures” below.
“Our results continue to reflect solid demand and operational
execution globally, including our operations in Germany,” said
Vicki Holt, President and Chief Executive Officer. “Revenue was at
the top end of our guidance and our EPS exceeded our estimates. We
also continue to generate strong cash flow from operations.
“During the quarter, we improved gross margin on a sequential
basis and managed our operating expenses while completing our moves
in North Carolina and Japan. We accelerated the launch of our
overmolding process and also launched 5-axis machining. These
actions set us up to deepen our relationships with our customers
and capitalize on the market opportunities.”
Additional Third Quarter 2016 Highlights include:
- Gross margin was 57.2 percent of
revenue for the third quarter compared with 59.4 percent for the
third quarter of 2015 and 56.4 in the second quarter of 2016. The
80 basis point sequential improvement in gross margin is
attributable to improved margins at Alphaform and execution in our
injection molding and CNC machining businesses.
- GAAP operating margin was 21.7 percent
of revenue during the third quarter of 2016 compared to 25.7
percent for the third quarter of 2015. On a non-GAAP basis,
operating margin was 25.0 percent for the third quarter of 2016.
See “Non-GAAP Financial Measures” below.
- The Company generated cash from
operations of $19.6 million during the third quarter. Cash and
investments increased $11.3 million during the quarter to $175.6
million at September 30, 2016.
“Proto Labs is a business that helps companies and entrepreneurs
get their products to market faster than their competition. The
current trends in the market require companies to be more
innovative and nimble as the internet of things, mass customization
and quickly changing demands from consumers require accelerated
product development. We are in a strong position to capitalize on
this long term trend.
“There is uncertainty in the market right now due to the
election in the United States and Brexit in Europe and that
uncertainty is impacting the economy. Our business is not immune to
that impact. While the current economic environment is challenging,
we are focused on our internal processes, in both sales and
operations, to position ourselves as economic conditions improve.
We remain very optimistic about the outlook for Proto Labs. We are
fortunate to serve a large, underpenetrated market with a unique
value proposition, unsurpassed service and quality for customers,
and the commitment and employee talent to successfully execute our
strategy for profitable growth,” Ms. Holt concluded.
Non-GAAP Financial Measures
The company has included non-GAAP adjusted revenue growth that
excludes the impact of changes in foreign currency exchange rates
and legacy revenue excluding the revenue contribution from
Alphaform from total revenues in this press release to provide
investors with additional information regarding the company’s
financial results. Management believes these metrics are useful in
evaluating the underlying business trends and ongoing operating
performance of the company.
The company has also included non-GAAP operating margin,
adjusted for stock-based compensation expense, amortization
expense, impairment on assets and charges related to the exit of
facilities (collectively, “non-GAAP operating margin”), in this
press release to provide investors with additional information
regarding the company’s financial results.
The company has also included non-GAAP net income, adjusted for
stock-based compensation expense, amortization expense, unrealized
foreign currency activity, impairment on assets and charges related
to the exit of facilities (collectively, “non-GAAP net income”), in
this press release to provide investors with additional information
regarding the company’s financial results.
The company has provided below a reconciliation of non-GAAP
operating margin to operating margin and non-GAAP net income to net
income, the most directly comparable measures calculated and
presented in accordance with GAAP. Non-GAAP operating margins and
non-GAAP net income are used by the company’s management and board
of directors to understand and evaluate operating performance and
trends and provide useful measures for period-to-period comparisons
of the company’s business. Accordingly, the company believes that
non-GAAP operating margin and non-GAAP net income provide useful
information to investors and others in understanding and evaluating
operating results in the same manner as our management and board of
directors.
Conference Call
The company has scheduled a conference call to discuss its third
quarter financial results today, October 27, 2016 at 8:30 a.m. ET.
To access the call in the U.S. please dial 877-709-8150. Outside
the U.S. please dial 201-689-8354. No participant code is required.
A simultaneous webcast of the call will be available via the
investor relations section of the Proto Labs website and the
following link: http://edge.media-server.com/m/p/o7y5fsbx/lan/en. A
replay will be available for 14 days following the call on the
investor relations section of Proto Labs’ website.
About Proto Labs, Inc.
Proto Labs is the world’s fastest digital manufacturing source
for custom prototypes and low-volume production parts. The
technology-enabled company uses advanced 3D printing, CNC machining
and injection molding technologies to produce parts within days.
The result is an unprecedented speed-to-market value for product
designers and engineers worldwide. Visit protolabs.com for more
information.
Forward-Looking Statements
Statements contained in this press release regarding matters
that are not historical or current facts are “forward-looking
statements” within the meaning of The Private Securities Litigation
Reform Act of 1995. These statements involve known and unknown
risks, uncertainties and other factors which may cause the results
of Proto Labs to be materially different than those expressed or
implied in such statements. Certain of these risk factors and
others are described in the “Risk Factors” section within reports
filed with the SEC. Other unknown or unpredictable factors also
could have material adverse effects on Proto Labs’ future results.
The forward-looking statements included in this press release are
made only as of the date hereof. Proto Labs cannot guarantee future
results, levels of activity, performance or achievements.
Accordingly, you should not place undue reliance on these
forward-looking statements. Finally, Proto Labs expressly disclaims
any intent or obligation to update any forward-looking statements
to reflect subsequent events or circumstances.
Proto Labs, Inc. Condensed Consolidated Balance
Sheets (In thousands)
September 30, December 31,
2016 2015
(Unaudited)
Assets
Current assets Cash and cash equivalents $ 68,218 $ 47,653
Short-term marketable securities 39,028 33,201 Accounts receivable,
net 37,261 36,125 Inventory 9,930 9,771 Income taxes receivable -
6,028 Other current assets 5,392 5,224 Total current
assets 159,829 138,002 Property and equipment, net 142,722
125,475 Long-term marketable securities 68,387 64,789 Goodwill
28,916 28,916 Other intangible assets, net 2,817 3,337 Other
long-term assets 1,374 517 Total assets $ 404,045 $
361,036
Liabilities and shareholders'
equity
Current liabilities Accounts payable $ 10,703 $ 13,643 Accrued
compensation 10,330 9,993 Accrued liabilities and other 3,612 2,626
Income taxes payable 541
-
Total current liabilities 25,186 26,262 Long-term deferred
tax liabilities 4,247 4,240 Other long-term liabilities 3,795 2,889
Shareholders' equity 370,817 327,645
Total liabilities and shareholders'
equity
$
404,045 $
361,036
Proto Labs, Inc. Condensed
Consolidated Statements of Operations (In thousands, except
share and per share amounts) (Unaudited) Three
Months Ended Nine Months Ended September
30, September 30,
2016
2015
2016
2015
Revenue Injection Molding (Protomold) $ 46,445 $ 41,971 $ 134,376 $
119,521 CNC Machining (Firstcut) 21,781 19,833 60,510 54,788 3D
Printing (Fineline) 9,850 6,038 28,059 16,038 Other
97 - 2,757
- Total revenue 78,173 67,842 225,702 190,347
Cost of revenue
33,448
27,517 99,077
77,218 Gross profit 44,725 40,325 126,625 113,129
Operating expenses Marketing and sales 11,787 10,027 34,182
28,383 Research and development 5,976 4,760 17,110 13,471 General
and administrative
10,020
8,134 28,397
20,683
Total operating expenses
27,783 22,921
79,689 62,537 Income from
operations 16,942 17,404 46,936 50,592 Other income (expense), net
625 593
2,342 100 Income before income
taxes 17,567 17,997 49,278 50,692 Provision for income taxes
5,585 5,615
15,943 16,171 Net income
$ 11,982 $
12,382 $ 33,335
$ 34,521 Net income per share:
Basic
$ 0.45 $ 0.47
$ 1.27 $ 1.33
Diluted
$ 0.45 $
0.47 $ 1.26 $
1.31 Shares used to compute net income per
share: Basic 26,416,041 26,083,405 26,334,738 25,952,451 Diluted
26,609,878 26,381,313 26,539,078 26,290,758
Proto Labs, Inc. Condensed Consolidated Statements of
Cash Flows (In thousands) (Unaudited)
Nine Months Ended September 30, 2016
2015 Operating activities Net income $ 33,335 $
34,521 Adjustments to reconcile net income to net cash provided by
operating activities: Depreciation and amortization 12,831 10,422
Stock-based compensation expense 5,260 4,515 Deferred taxes 495
(310 ) Excess tax benefit from stock-based compensation (1,965 )
(5,212 ) Amortization of held-to-maturity securities 881 936 Loss
on impairment of assets 455 - Other (1,381 ) - Changes in operating
assets and liabilities
6,266
(3,588 ) Net cash provided by operating
activities
56,177 41,284
Investing activities Purchases of property and
equipment (30,981 ) (27,259 ) Purchases of marketable securities
(56,213 ) (42,674 ) Proceeds from sales and maturities of
marketable securities
45,907
40,899 Net cash used in investing activities
(41,287 ) (29,034
) Financing activities Payments on debt
- (107 ) Acquisition-related contingent consideration (400 ) (1,400
) Proceeds from exercises of stock options and other 4,168 5,165
Excess tax benefit from stock-based compensation
1,965 5,212 Net cash provided by
financing activities
5,733
8,870 Effect of exchange rate changes on cash and cash
equivalents
(58 )
(318 ) Net increase in cash and cash
equivalents 20,565 20,802
Cash and cash equivalents,
beginning of period 47,653
43,329 Cash and cash equivalents, end of period
$ 68,218 $
64,131
Proto
Labs, Inc. Reconciliation of GAAP to Non-GAAP Net Income per
Share (In thousands, except share and per share amounts)
(Unaudited) Three Months Ended Nine Months
Ended September 30, September
30,
2016
2015
2016
2015
Non-GAAP net income, adjusted for
stock-based compensation expense, amortization expense, unrealized
(gain) loss on foreign currency, acquisition costs, impairment on
assets and charges related to the exit of facilities
GAAP net income $ 11,982 $ 12,382 $ 33,335 $ 34,521 Add back:
Stock-based compensation expense 1,719 1,606 5,260 4,515
Amortization expense 163 186 520 559 Impairment on assets - - 455 -
Facilities-related charges 731 - 1,150 - Acquisition costs - 648 -
648 Unrealized (gain) loss on foreign currency
(330 ) (407
) (1,460 )
211 Total adjustments 2
2,283
2,033 5,925
5,933 Income tax benefits on adjustments1
(743 ) (708
) (2,054 )
(1,851 ) Non-GAAP net income
$ 13,522 $
13,707 $ 37,206
$ 38,603 Non-GAAP net
income per share: Basic
$ 0.51
$ 0.53 $ 1.41
$ 1.49 Diluted
$
0.51 $ 0.52 $
1.40 $ 1.47 Shares
used to compute non-GAAP net income per share: Basic 26,416,041
26,083,405 26,334,738 25,952,451 Diluted 26,609,878 26,381,313
26,539,078 26,290,758
1 For the three months ended September 30,
2016 and 2015, income tax effects were calculated reflecting an
effective GAAP tax rate of 31.8% and 31.2%, respectively, and an
effective non-GAAP tax rate of 31.9% and 31.6%, respectively. For
the nine months ended September 30, 2016 and 2015, income tax
effects were calculated reflecting an effective GAAP tax rate of
32.4% and 31.9%, respectively, and an effective non-GAAP tax rate
of 32.6% and 31.8%, respectively. The difference between our GAAP
and non-GAAP tax rate for the three and nine months ended September
30, 2016 was primarily due to the tax effect of stock-based
compensation expense, amortization expense, unrealized gain on
foreign currency, impairment on assets and charges related to the
exit of facilities. The difference between our GAAP and non-GAAP
tax rate for the three and nine months ended September 30, 2015 was
primarily due to stock-based compensation expense, amortization
expense, unrealized (gain) loss on foreign currency and acquisition
costs. 2 Stock-based compensation expense, amortization
expense, unrealized (gain) loss on foreign currency, acquisition
costs, impairment on assets and charges related to the exit of
facilities were included in the following GAAP consolidated
statement of operations categories:
Three Months
Ended Nine Months Ended September
30, September 30,
2016
2015
2016
2015
Cost of revenue $ 558 $ 136 $ 999 $ 378 Marketing and sales 250 288
741 796 Research and development 310 335 1,084 964 General and
administrative 1,495 1,681 4,561 3,584 Other income (expense), net
(330 ) (407
) (1,460 )
211 Total adjustments
$
2,283 $ 2,033 $
5,925 $ 5,933
Proto Labs, Inc.
Reconciliation of GAAP to Non-GAAP Operating Margin (In
thousands) (Unaudited) Three Months Ended
Nine Months Ended September 30,
September 30,
2016
2015
2016
2015
Revenue $ 78,173 $ 67,842 $ 225,702 $ 190,347 Income from
operations
16,942 17,404
46,936 50,592 GAAP
operating margin 21.7% 25.7% 20.8% 26.6% Add back: Stock-based
compensation expense 1,719 1,606 5,260 4,515 Amortization expense
163 186 520 559 Impairment on assets - - 455 - Facilities-related
charges 731 - 1,150 - Acquisition costs
-
648 -
648 Total adjustments
2,613
2,440 7,385
5,722
Non-GAAP income from operations adjusted
for stock-based compensation expense, amortization expense,
impairment on assets, facilities-related charges and acquisition
costs
$ 19,555 $
19,844 $ 54,321
$ 56,314 Non-GAAP operating margin 25.0%
29.3% 24.1% 29.6%
Proto Labs, Inc.
Comparison of GAAP to Non-GAAP Revenue Growth (In
thousands) (Unaudited)
Three Months Ended %
Change Nine Months Ended % Change
September 30, % Constant
September 30, % Constant
2016
2015
Change
Currencies1
2016
2015
Change
Currencies1 Revenues United
States $ 59,574 $ 54,408 9.5 % 9.5 % $ 169,364 $ 154,107 9.9 % 9.9
% Europe 15,610 11,297 38.2 % 44.7 % 48,518 30,161 60.9 % 65.7 %
Japan
2,989 2,137
39.9
% 17.3 %
7,820 6,079 28.6
% 14.8 % Total Revenue
$ 78,173 $
67,842 15.2 %
15.6 % $
225,702 $ 190,347
18.6 % 18.9 %
1 Revenue growth for the three- and nine-month periods ended
September 30, 2016 has been recalculated using 2015 foreign
currency exchange rates in effect during comparable periods to
provide information useful in evaluating the underlying business
trends excluding the impact of changes in foreign currency exchange
rates.
Three Months Ended % Change Nine Months
Ended % Change September 30,
%
Constant September 30,
%
Constant
2016
2015
Change2
Currencies2
2016
2015
Change2
Currencies2
Revenues United States $ 59,574 $ 54,408 9.5 % 9.5 % $ 169,364 $
154,107 9.9 % 9.9 % Europe 11,629 11,297 2.9 % 9.5 % 34,871 30,161
15.6 % 20.4 % Japan
2,989
2,137 39.9 %
17.3 % 7,820
6,079 28.6 %
14.8 % Total Revenue
$
74,192 $ 67,842
9.4 % 9.7 %
$ 212,055 $
190,347 11.4 %
11.7 %
2 Revenue growth for the three- and nine-month
periods ended September 30, 2016 has been recalculated to exclude
revenue earned from our acquisition of Alphaform, and using 2015
foreign currency exchange rates in effect during comparable periods
to provide information useful in evaluating the underlying business
trends excluding the impact of changes in foreign currency exchange
rates.
Proto Labs, Inc. Revenue by
Geography - Based on Shipping Location (In thousands)
(Unaudited) Three Months
Ended Nine Months Ended September
30, September 30,
2016
2015
2016
2015
Revenues Domestic United States $ 55,677 $ 50,214 $ 158,095 $
144,357 International Europe 15,610 11,297 48,518 30,161 Japan
2,989 2,137 7,820 6,079 United States
3,897
4,194 11,269
9,750 Total international
22,496
17,628 67,607
45,990 Total revenue
$
78,173 $ 67,842
$ 225,702 $
190,347
Proto Labs, Inc. Product Developer
Information (Unaudited)
Three Months Ended Nine Months Ended September
30, September 30, 2016 2015 2016
2015 Unique product developers and engineers served
14,271 12,541 26,528
22,633 Note: the data above does not include
product developers and engineers who purchased products
attributable to our acquisition of Alphaform during the periods
presented.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20161027005573/en/
Proto Labs, Inc.Investor Relations:John Way,
763-479-7726john.way@protolabs.comorJenifer Kirtland,
408-656-9496jkirtland@evcgroup.comorMedia Relations:Bill Dietrick,
763-479-7664bill.dietrick@protolabs.com
Proto Labs (NYSE:PRLB)
Historical Stock Chart
From Mar 2024 to Apr 2024
Proto Labs (NYSE:PRLB)
Historical Stock Chart
From Apr 2023 to Apr 2024